Navigation Links
Lance Armstrong Update: Arrogant Even After Conceding Doping Charges, Asserts Former White House & WADA Spokesman Robert Weiner; Victory for Clean Sport but "Dark Message" Is Science Must Catch Up to Masking Agents Allowing Cheating

WASHINGTON, Aug. 24, 2012 /PRNewswire-USNewswire/ -- "Lance Armstrong's arrogance even now after conceding on doping charges by USADA  – his belief he knows more than the enforcement  system and can beat it  – is what finally brought him down," asserted Robert Weiner, the former White House Drug Policy spokesman and former WADA Olympics spokesman.  Weiner, who was the spokesman for the Office of National Drug Policy and worked to help create WADA and USADA, said, "Armstrong conceded only because he would be beaten by over ten witnesses' testimony in arbitration who saw him dope and who had spoken with investigators.  His statement that 'Everyone knows who won' is outrageous and wrong.  Everyone now knows who cheated. This is a sad but huge victory for clean sport, and for WADA and USADA's ongoing mission to end drug cheating and assure youth that they will have an even playing field without drugs determining the champion."

"The real victory in Armstrong's concession is children who can believe that even the most famous athletes can get caught if they cheat," Weiner stated.

"However, a dark message from Armstrong's final concession," Weiner said, "is that top athletes like him continue to use masking agents to beat the science of drug testing. It's only because over ten witnesses saw Armstrong dope and came forward that he was overwhelmed and had to give up his fight.  For years, he's defied the system because he successfully masked his drug use with other drugs that blocked positive tests. If you're rich enough, you can do that. Armstrong only conceded after witnesses spoke out, despite hundreds of tests that erroneously showed him clean and let him keep racing, while he smugly was asserting all the while that he 'didn't dope.'"

"I remember Frank Shorter, USADA's Chairman and an American Olympic marathon gold medalist, telling me during the Sydney Olympics, while were waiting to start a drug-testing news conference, 'Watch who comes late to the Games so they drop their positives before we can test them,' and Armstrong was one of those," Weiner said.  Armstrong then won his Olympic bronze in Sydney.  "There was nothing the science could do then, and now.  It misses huge quantities of dopers, though the testing is getting better and better and more sophisticated."

"That's why it's so important for WADA and USADA to continue using the new strategy—the same that unearthed Marion Jones' cheating despite her similar years of false claims of innocence – of collateral evidence and testimony, not just using the testing. That is a relatively new development," Weiner explained.

Weiner ran track in high school and college and continues to compete as a master, earning a bronze and making All-American in the steeplechase at this month's USA Masters Track and Field Championships in Illinois. "I want to see clean sport, and today's development is a huge step toward making that a reality," he concluded.

Contact: Robert Weiner 301-283-0821 or 202-306-1200

SOURCE Robert Weiner Associates
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
2. Fetal Surveillance Company, PeriGen, Inc., to Collaborate with National Institute of Child Health and Human Development to Research Fetal Heart Rate Patterns During Labor
3. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
4. Celleration, Inc. Announces First Patient Enrollment in In-Balance VLU Randomized Control Trial
5. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
6. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
7. Onyx Pharmaceuticals To Report Second Quarter 2012 Financial Results After Market On August 1, 2012
8. Masimo to Report Second Quarter 2012 Financial Results after Market Close on August 1
9. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
10. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
11. One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
Post Your Comments:
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):